Skip to content

First published Wednesday 25 May 2016.

Mailing list

Be Inspired

Join thousands of active subscribers and hear about the brave children, dedicated researchers, and world-leading science at Telethon Kids Institute.

You can opt-out at any time from this free series.




 

We guarantee 100% privacy. Your information will not be shared.

media enquiries

Media Contacts

Please direct general enquiries to our reception on (08) 6319 1000.

Please direct media enquiries to our media team:

Amy Birch
Senior Communications Officer 
Phone: +61 8 6319 1671 (office) 0437 575 875 (mobile)
Email: Amy Birch

Tammy Gibbs 
Communications Manager 
Phone: +61 8 6319 1645 (office) 0408 946 698 (mobile)
Email: Tammy Gibbs

Telethon Kids researchers are leading a nationwide case-control study which is examining whether children who receive the whole cell pertussis vaccine in infancy are at lower risk of developing food allergies compared with infants who have not. This study should be finished by the middle of 2018.

We also plan to pilot the use of whole cell pertussis vaccines in a mixed whole/ acellular vaccine schedule, with the expectation this will result in longer lasting protection against whooping cough and might also be a feasible way of lowering the risk of allergic diseases. Currently the acellular vaccine is the only one used in Australia.